Atlas Trials

A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer

Clinical trial NCT02059213 · COMPLETED

Trial details

NCT number
NCT02059213
Sponsor
University of Michigan Rogel Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2014-06-01
Primary completion
2017-09-09
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.